朱伟明
2018-11-12 16:52  

朱伟明,博士,教授,博士研究生导师,硕士研究生导师(学术)。

研究方向:天然药物化学与微生物药物化学研究,特别是特殊环境微生物中含氮和卤代天然产物的发现与优化。

个人简介:正在承担或主持完成973、863、NSFC、国家“重大新药创制”专项等国家级研究课题25项,整合形成了以集成化学特性与生物活性为基础的药源微生物“Talented 菌株”的快速筛选技术体系;通过发酵优化和结构优化,发现新化合物700余个,其中8个新骨架化合物被Nat Prod Rep选为热点化合物;在《Journal of American Chemical Society》、《Organic Letters》、《Journal of Natural Products》、《Tetrahedron》等知名学术期刊上发表SCI收录的研究论文174篇,论文H-指数为41(Google Schoolar)、他引H-指数为32(Researchgate);多次在国内外的学术大会上作大会报告、邀请报告或会议主持人;申请国家发明专利35件(授权14件、PCT2件)。获得2006中国药学会“施维雅青年药物化学奖”,入选贵州省2014年度“百人领军人才”,曾担任国家自然科学基金委员会(NSFC)第13、14届医学部药学学科专家组成员(“二审专家”),现任中国菌物学会菌物化学专业委员会副主任、中国海洋湖沼学会微生物海洋学分会常务理事、中国海洋生物化学与分子生物学分会理事、中国药学会海洋药物专业委员会委员、山东省药学会中药与天然药物专业委员会副主任委员、《中国抗生素》杂志编委、《中国海洋药物》杂志编委。


主持国家级课题:

1. “南极磷虾微生物中氟代天然产物的发现与活性研究” (2019−2022,国家自然科学基金面上项目,41876172,73.8万);

2. “红树林特境植物与微生物来源抗感染先导化合物的发现与结构优化” (2016−2019,国家自然科学基金联合资助重点项目,U1501221,280万,副组长)

3. “海洋抗结直肠癌活性化合物的多样性与机制研究”( 2018.01–2018.12,国家自然科学基金应急项目—主任基金,81741150,23.6万元);

4. “中国海洋微生物和泰国药用植物中具有抗衰老相关病活性的天然产物的发现、优化与作用机制研究” (2015−2018,国家自然科学基金国际(地区)合作交流项目,81561148012,300万);

5. “浒苔共附生微生物及其含氮、卤代等克生活性产物研究”(2014−2017,国家自然科学基金,41376148,83万),

6. “环境胁迫增加海洋真菌的化学多样性研究”(2012−2015,国家自然科学基金面上项目,21172204,60万);

7. “深海微生物活性物质的发现及其生物合成技术”(2012–2015,863子课题,No. 2012AA092104-1,170万);

8. “海洋微生物次生代谢产物的生理活性和作用机制”(2010-2014,国家重点基础研究发展计划(973计划)课题,(2010CB833804,304.5万,共同主持);

9. “逆转多药耐药抗乳腺癌化合物HDZ-137成药性评价”(2011–2014,863课题,2011AA09070106,190万,共同主持);

10. “PKC抑制活性的双吲哚马来酰亚胺和吲哚咔唑生物碱的合成与构效关系研究”(2010−2012,国家自然科学基金面上项目,30973680,39万);

11. “PKC靶向抗瘤候选药物ACT-007的研究与开发”(2007−2010,863重点课题,2007AA091502,281万);

12. “海洋靶向抗癌先导药物MDZ-03的化学及药效学研究”(2009-2010,国家“重大新药创制”科技重大专项课题,2009ZX09103-46,147.83万);

13. “嗜盐微生物抗肿瘤活性成分的研究”(2007−2009,国家自然科学基金面上项目,30670219,26万);

14. “海洋微生物中抗癌等活性先导化合物的发现和优化”(2003-2005,863重点课题,2003AA624020,120万);

15. “新的蛋白激酶C抑制剂ACT-007衍生物的合成及其抗癌构效关系研究”(2006-2008,国家自然科学基金面上项目,30572246,23万);

16. “嗜盐微生物抗肿瘤活性成分的探索性研究”(2004-2005,国家自然科学基金主任基金项目,30470196,8万)。

代表性论文:

1. Yiguang Zhu Qingbo Zhang, Sumei Li, Qinheng Lin, Peng Fu, Guangtao Zhang, Haibo Zhang, Rong Shi, Weiming Zhu*, and Changsheng Zhang*, Insights into caerulomycin A biosynthesis: a two-component monooxygenase CrmH-catalyzed oxime formation. J. Am. Chem. Soc., 2013, 135(50): 18750–18753(影响因子10.68

2. Xia Li, Hongguang Ma, Lin Li, Yifan Chen, Xiao Sun, Zizheng Dong, Jing-Yuan Liu, Weiming Zhu,* Jian-Ting Zhang.* Novel synthetic bisindolylmaleimide alkaloids inhibit STAT3 activation by binding to the SH2 domain and suppress breast xenograft tumor growth. Oncogene 2018, 37(18): 2469–2480. doi:10.1038/s41388-017-0076-0影响因子7.52

3. Peng Fu, Yiguang Zhu, Xiangui Mei, Yi Wang, Haijian Jia, Changsheng Zhang*, Weiming Zhu*. Acyclic Congeners from Actinoalloteichus cyanogriseus Provide Insights into Cyclic Bipyridine Glycoside Formation. Org Lett 2014, 16(16): 4264–4267.影响因子6.32

4. Peng Fu, Fandong Kong, Xia Li, Yi Wang, Weiming Zhu*. Cyanogramide with a New Spiro[indolinone-pyrroloimidazole] Skeleton from Actinoalloteichus cyanogriseus. Org Lett 2014, 16(14): 37083711.

5. Peng Fu, Yibin Zhuang, Yi Wang, Peipei Liu, Xin Qi, Kangbo Gu, Daojing Zhang, Weiming Zhu*, New Indolocarbazoles from a mutant strain of the marine-derived actinomycete Streptomyces fradiae 007M135. Org Lett 2012, 14(24): 6194–6197.

6. Peng Fu, Chunli Yang, Yi Wang, Peipei Liu, Yiming Ma, Lei Xu, Mingbo Su, Kui Hong*, Weiming Zhu*, Streptocarbazoles A and B, two novel indolocarbazoles from the marine-derived actinomycete strain Streptomyces sp. FMA. Org Lett 2012, 14(9): 2422–2425.

7. Yiguang Zhu, Peng Fu, Qinheng Lin, Guangtao Zhang, Haibo Zhang, Sumei Li, Jianhua Ju, Weiming Zhu,* Changsheng Zhang*, Identification of caerulomycin A gene cluster implicates a tailoring amidohydrolase. Org Lett 2012, 14(11): 2666–2669.

8. Xiaoqiu Cui, Guoliang Zhu, Haishan Liu, Guoliang Jiang, Yi Wang*, Weiming Zhu*. Diversity and function of the Antarctic krill microorganisms from Euphausia superba. Sci. Rep. 2016, 6: 36496. 影响因子5.58

9. Zhengbo Chen, Jiejie Hao, Liping Wang, Yi Wang*, Fandong Kong, Weiming Zhu*. New α-glucosidase inhibitors from marine algae-derived Streptomyces sp. OUCMDZ-3434. Sci Rep 2016, 6: 20004;

10. Yaqin Fan, Yi Wang, Peng Fu*, Arthit Chairoungdua, Pawinee Piyachaturawat, Weiming Zhu*. Secopaxilline A, an indole-diterpenoid derivative from an aciduric Penicillium fungus, its identification and semisynthesis. Org. Chem. Front. 2018, 5(19): 2835–2839. (影响因子5.46

11. Yiguang Zhu, Jinxin Xu, Xiangui Mei, Zhan Feng, Liping Zhang, Qingbo Zhang, Guangtao Zhang, Weiming Zhu*, Jinsong Liu*, and Changsheng Zhang*. Biochemical and structural insights into the aminotransferase CrmG in caerulomycin biosynthesis. ACS Chem Biol 2016, 11(4): 943-952(影响因子5.33

12. Miaomiao Wang, Shuyao Wang, Wei Wang*, Yi Wang, Hui Wang, Weiming Zhu*. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway. Antiviral Research 2017, 143: 74–84.影响因子4.91

13. Liping Wang, Xiuli Han, Guoliang Zhu, Yi Wang, Arthit Chairoungdua, Pawinee Piyachaturawat, Weiming Zhu*. Polyketides from the endophytic fungus Cladosporium sp. isolated from the mangrove plant Excoecaria agallocha. Front. Chem. 2018, 6: 344. (影响因子4.16

14. Haishan Liu, Guoliang Zhu, Yaqin Fan, Yuqi Du, Mengmeng Lan, Yibo Xu, Weiming Zhu*. Natural products research in China from 2015 to 2016. Front. Chem. 2018, 6: 45.

15. Dongyang Wang, Cong Wang, Pengyan Gui, Haishan Liu, Sameh M. H. Khalaf, Elsayed A. Elsayed, Mohammed A. M. Wadaan, Wael N. Hozzein*, Weiming Zhu*. Identification, bioactivity, and productivity of actinomycins from the marine-derived Streptomyces heliomycini. Front. Microbiol. 2017, 8: 1147. (影响因子4.02

16. Tonghan Zhu, Zhenyu Lu, Jie Fan, Liping Wang, Guoliang Zhu, Yi Wang, Xia Li, Kui Hong, Pawinee Piyachaturawat, Arthit Chairoungdua, Weiming Zhu.* Ophiobolins from the mangrove fungus Aspergillus ustus. J Nat Prod 2018, 81(1): 2–9. (影响因子3.28

17. Cong Wang, Lei Guo, Jiejie Hao, Liping Wang, Weiming Zhu*. α-Glucosidase inhibitors from the marine-derived fungus Aspergillus flavipes HN4-13. J Nat Prod 2016, 79(11): 2977-2981.

18. Fandong Kong, Yi Wang, Peipei Liu, Tianhan Dong, and Weiming Zhu*, Thiodiketopiperazines from the Marine-Derived Fungus Phoma sp. OUCMDZ-1847. J Nat Prod 2014, 77 (1): 132–137.

19. Yaqin Fan, Yi Wang, Peipei Liu, Peng Fu, Tonghan Zhu, Wei Wang, and Weiming Zhu*, Indole-diterpenoids with anti-H1N1 activity from the aciduric fungus Penicillium camemberti OUCMDZ-1492. J Nat Prod 2013, 76(7): 1328–1336.

20. Xiao Sun, Lin Li, Hong-Guang Ma, Pu Sun, Qi-Lin Wang, Ting-Ting Zhang, Yue-Mao Shen, Wei-Ming Zhu*, Xia Li*. Bisindolylmaleimide alkaloid BMA 155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway. Acta Pharmacol Sin 2017, 38(4): 524–538. advance online publication, Mar 6 2017; Doi:10.1038/aps.2016.171影响因子3.17

21. Yuqi Du, Jian Sun, Qianhong Gong, Yi Wang, Peng Fu,* Weiming Zhu*. New αpyridones with quorum-sensing inhibitory activity from diversity-enhanced extracts of a Streptomyces sp. derived from marine algae. J Agric Food Chem 2018, 66(8): 1807–1812.影响因子3.15

22. Kunlai Sun, Guoliang Zhu, Jiejie Hao, Yi Wang, Weiming Zhu.* Chemical-epigenetic method to enhance the chemodiversity of the marine algicolous fungus, Aspergillus terreus OUCMDZ-2739. Tetrahedron 2018, 74(1): 83–87.影响因子2.65

23. Haishan Liu, Zhengbo Chen, Guoliang Zhu, Liping Wang, Yuqi Du, Yi Wang, Weiming Zhu*, Phenolic polyketides from the marine alga-derived Streptomyces sp. OUCMDZ-3434. Tetrahedron 2017, 73(36): 5451–5455.

24. Liping Wang, Xiangui Mei, Cong Wang, Weiming Zhu*. Biomimetic semi-synthesis of fradcarbazole A and its analogues. Tetrahedron 2015, 71(42): 7990–7997.

25. Liping Wang, Weiming Zhu*, Versicolactones A and B: total synthesis and structure revision. Tetrahedron Lett 2013, 54(49): 6729–6731(影响因子2.68

26. Zhihong Xu, Yapeng Zhang, Haichao Fu, Huimin Zhong, Kui Hong*, Weiming Zhu*. Antifungal quinazolinones from marine-derived Bacillus cereus and their preparation, Bioorg Med Chem Lett 2011, 21(13): 4005–4007. 影响因子2.55

27. Yanchao Xu, Cong Wang, Haishan Liu, Guoliang Zhu, Peng Fu, Liping Wang*, Weiming Zhu*. Meroterpenoids and isocoumarinoids from a Myrothecium fungus associated with Apocynum venetum. Mar. Drugs 2018, 16(10): 363;(影响因子4.38

28. Yaqin Fan, Cong Wang, Liping Wang, Arthit Chairoungdua, Pawinee Piyachaturawat, Peng Fu*, Weiming Zhu*. New ansamycins from the deep-sea-derived bacterium Ochrobactrum sp. OUCMDZ-2164. Mar. Drugs 2018, 16(8): 282

29. Cong Wang, Adeep Monger, Liping Wang, Peng Fu, Pawinee Piyachaturawat, Arthit Chairoungdua*, Weiming Zhu*. Precursor-directed generation of indolocarbazoles with topoisomerase IIα inhibitory activity. Mar. Drugs 2018, 16(5), 168

30. Guoliang Zhu, Fandong Kong, Yi Wang, Peng Fu,* Weiming Zhu.* Cladodionen, a cytotoxic hybrid polyketide from the marine-derived Cladosporium sp. OUCMDZ-1635. Mar Drugs 2018, 16(2), 71.

31. Cuiting Lv, Wenxing Qin, Tonghan Zhu, Shanjian Wei, Kui Hong,* Weiming Zhu,* Ruohua Chen,* Caiguo Huang,* Ophiobolin O isolated from Aspergillus ustus induces G1 arrest of MCF-7 cells through interaction with AKT/GSK3β/Cyclin D1 signaling. Mar Drugs 2015, 13(1): 431443.

32. Kunlai Sun, Ye Li, Lei Guo, Yi Wang, Peipei Liu, Weiming Zhu*. Indole diterpenoids and isocoumarin from the fungus, Aspergillus flavus, isolated from the prawn, Penaeus vannamei. Mar Drugs 2014, 12(7): 39703981.

33. Yi Wang, Liping Wang, Yibin Zhuang, Fandong Kong, Cuixian Zhang and Weiming Zhu*. Phenolic Polyketides from the Co-Cultivation of Marine-Derived Penicillium sp. WC-29-5 and Streptomyces fradiae 007. Mar Drugs 2014, 12(4): 2079–2088.

34. Pei Wang, Fandong Kong, Jingjing Wei, Yi Wang, Wei Wang, Kui Hong*, Weiming Zhu*.  Alkaloids from the mangrove-derived actinomycete Jishengella endophytica 161111. Mar Drugs 2014, 12(1): 477–490.

35. Fandong Kong, Chengying Zhao, Jiejie Hao, Cong Wang, Wei Wang, Xiaolong Huang, Weiming Zhu*. New a-glucosidase inhibitors from a marine sponge-derived fungus, Aspergillus sp. OUCMDZ-1583. RSC Adv 2015, 5(84), 68852–68863(影响因子3.71

36. Peng Fu, Peipei Liu, Qianhong Gong, Yi Wang, Pei Wang, Weiming Zhu*, α-Pyrones from the marine-derived actinomycete Nocardiopsis dassonvillei subsp. dassonvillei XG-8-1. RSC Adv 2013, 3(43): 20726–20731.

37. Xiaoping Peng, Yi Wang, Tonghan Zhu, Weiming Zhu*. Pyrazinone derivatives from the coral-derived Aspergillus ochraceus LCJ11-102 under high iodide salt. Arch Pharm Res 2018, 41(2): 184–191.影响因子2.324

38. Yanzheng Jin, Shidong Qin, Hai Gao, Guoliang Zhu, Wei Wang, Weiming Zhu,* Yi Wang*. An anti-HBV anthraquinone from aciduric fungus Pennicillium sp. OUCMDZ-4736 under low pH stress. Extremophiles 2018, 22(1): 39–45. (影响因子2.24

39. Tonghan Zhu, Zhengqian Chen, Peipei Liu, Yi Wang, Zhihong Xin, Weiming Zhu*, New rubrolides from the marine-derived fungus Aspergillus terreus OUCMDZ-1925. J Antibiot (Tokyo). 2014, 67(4): 315–318. (影响因子2.03


公开及授权的发明专利:

1. 朱伟明, 梅显贵, 付鹏, 等. 联吡啶类生物碱、其制备方法和用途. PCT专利,申请号:PCT/CN2017/110799,申请日:2017.11.14

2. 朱伟明,马红光,王立平,等,“双吲哚马来酰亚胺衍生物及其制备方法和用途”,PCT专利,申请号:PCT/CN2017/090349,申请日:2017.06.27

3. 朱伟明,梅显贵,王乂,刘培培,“5,5,6-多环含特特拉姆酸大环内酰胺类化合物及其制备方法和用途”,中国发明专利,申请号:201710181976.7,申请日:2017.03.24

4. 朱伟明,梅显贵,付鹏,刘培培,“联吡啶类生物碱、其制备方法和用途”,中国发明专利,申请号:201611014546.8,申请日:2016.11.15

5. 朱伟明,马红光,王立平,等,“双吲哚马来酰亚胺衍生物及其制备方法和用途”(抗肿瘤用途),中国发明专利,申请号:201610411630.7,申请日:2016.06.13

6. 朱伟明,马红光,王立平,等,“双吲哚马来酰亚胺衍生物及其制备方法和用途”(抗糖尿病用途),中国发明专利,申请号:201610415781.X, 申请日:2016.06.13

7. 洪葵,朱伟明,杨春丽,等,“一类新颖的十字孢碱类似物及其制备方法和用途”,中国发明专利ZL201010185370.9授权公告号:CN101948472B,授权日:2012.07.04

8. 朱伟明,徐志红,张亚鹏,等,“吲哚咔唑和双吲哚马来酰亚胺生物碱及其制备方法和应用”,中国发明专利专利号:ZL201010167113.2  公开号:CN101812097A,公开日:2010.08.25,授权日:2012.04.25

9. 朱伟明,卢圳域,洪葵,缪承杜,“蛇孢假壳素(ophiobolin)类二倍半萜烯化合物及其制备方法和用途”,中国发明专利ZL200810172946.0,公开日:20091202, 授权日:2011.08.10

10. 朱伟明,刘为忠、顾谦群,等,“苯醌类化合物及其制备方法和用途”,中国发明专利ZL200510055631.4,公开号:CN1686995,公开日:2005.10.26,授权日:2006.10.18

11. 朱伟明,顾谦群、刘为忠,等,“氢化木霉醇类化合物及其制备方法和用途”,中国发明专利ZL200510055629.7,公开号:CN1687073,公开日:2005.10.26,授权日:2007.05.30

12. 田伟生,王真,朱伟明,“17α, 22-双羟基呋甾化合物及其用途”,中国发明专利ZL200410024930.7,公 开号:CN1583784,公开日:2005.02.23,授权日:2006.09.06

13. 崔承彬,韩小贤,顾谦群,朱伟明,刘红兵,“吲哚咔唑生物碱及其制备方法和用途”,中国发明专利ZL200510051437.9,公开 号:CN1683374,公开日:2005.10.19,授权日:2007.02.07

14. 田伟生,朱伟明,许启海,王 真,“一类C22甾体化合物及其合成方法”,中国发明专利ZL200510111267.9,申 请 号:200510111267.9,公 开号:CN1775799,公开日:2006.05.24,授权日:2008.01.02



关闭窗口
 
     
 

版权所有 必赢bwin线路检测中心(官方)Official Website
TEL No. 86-0851-8416153  E-MAIL: yaoxueyuan@gmc.edu.cn
中国 ☆ 贵州省 ☆ 贵安新区大学城必赢bwin线路检测中心第五教学楼 ☆ 必赢bwin线路检测中心

 

 
Baidu
sogou